Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EFMOROCTOCOG ALFA vs ELAFIBRANOR: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

EFMOROCTOCOG ALFA vs ELAFIBRANOR: Safety Overview

Metric EFMOROCTOCOG ALFA ELAFIBRANOR
Total FAERS Reports 1,832 356
Deaths Reported 22 4
Death Rate 1.2% 1.1%
Hospitalizations 256 19
Average Patient Age 28.5 yrs 59.8 yrs
% Female Patients 1.9% 96.1%
FDA Approval Date N/A Jun 10, 2024
Manufacturer N/A Ipsen Biopharmaceuticals, Inc.
Route N/A ORAL
Marketing Status N/A Prescription